resveratrol has been researched along with Overweight in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 19 (73.08) | 24.3611 |
2020's | 7 (26.92) | 2.80 |
Authors | Studies |
---|---|
Abdollahi, S; Ali Sangouni, A; Mozaffari-Khosravi, H | 1 |
Dellino, M; Lupica, G; Malvasi, A; Mynbaev, O; Spyropoulou, K; Tinelli, A; Vimercati, A | 1 |
Anton, SD; Buford, TW; Leeuwenburgh, C; Manini, TM; Mankowski, RT; Qiu, P; Schneider, S; You, L | 1 |
Bergman, M; de Ligt, M; Essers, H; Fuentes, RM; Havekes, B; Moonen-Kornips, E; Schrauwen, P; Schrauwen-Hinderling, VB | 1 |
Gliemann, L | 1 |
Caputo, EL; Delpino, FM; Figueiredo, LM; Gigante, DP; Mintem, GC | 1 |
Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
Blaak, EE; Goossens, GH; Lucchesi, M; Most, J; Penders, J | 1 |
Baer, DJ; Chen, TY; Ferruzzi, MG; Gebauer, SK; Ho, L; Novotny, JA; Pasinetti, GM; Terekhov, AI | 1 |
Bombrich, M; Fritsche, A; Fritsche, L; Häring, HU; Heni, M; Kantartzis, K; Kunz, I; Lehn-Stefan, A; Machann, J; Peter, A; Schick, F; Schoop, R; Staiger, H; Stefan, N | 1 |
Anton, SD; Dotson, VM; Dzierzewski, JM; Ebner, N; Gurka, MJ; Kirton, J; Manini, TM; Mankowski, RT; Marsiske, M; Zlatar, ZZ | 1 |
Banach, M; Cicero, AFG; Fogacci, F | 1 |
Bendik, I; Blaak, EE; Boekschoten, MV; de Groot, P; Friedel, A; Goossens, GH; Jocken, JWE; Most, J; Warnke, I | 1 |
Berry, NM; Bryan, J; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
Dash, S; Lewis, GF; Morgantini, C; Szeto, L; Xiao, C | 1 |
Blaak, EE; Goossens, GH; Jocken, JW; Most, J | 1 |
Anton, SD; Doss, H; Embry, C; Leeuwenburgh, C; Lu, X; Manini, TM; Marsiske, M | 1 |
Mensink, RP; Plat, J; van der Made, SM | 1 |
Dolinsky, VW; Duhamel, T; McGavock, J; Robert, M; T' Jong, GW; Wicklow, B; Wittmeier, K | 1 |
Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M | 1 |
Christenson, J; McKune, A; Mellor, D; Naumovski, N; Roach, PD; Thomas, J; Whitby, SJ | 1 |
Chen, G; Huang, H; Liao, D; Pu, R; Xue, X; Zhu, Y | 1 |
Cui, X; Jing, X; Wu, X; Yan, M | 1 |
Avakian, SD; Goes, MFS; Leal, DP; Mansur, AP; Maranhão, RC; Roggerio, A; Strunz, CMC | 1 |
Berry, NM; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
Carpéné, C; Gomez-Zorita, S; Mercader, J; Tréguer, K | 1 |
3 review(s) available for resveratrol and Overweight
Article | Year |
---|---|
What is the effect of resveratrol on obesity? A systematic review and meta-analysis.
Topics: Body Mass Index; Body Weight; Humans; Obesity; Overweight; Resveratrol | 2021 |
The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials.
Topics: Anti-Inflammatory Agents; Dietary Supplements; Humans; Obesity; Overweight; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Weight Loss | 2016 |
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.
Topics: Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Humans; Insulin Resistance; Meta-Analysis as Topic; Obesity; Overweight; Randomized Controlled Trials as Topic; Reproducibility of Results; Resveratrol; Risk Factors; Stilbenes | 2016 |
17 trial(s) available for resveratrol and Overweight
Article | Year |
---|---|
Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial.
Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Humans; Iran; Non-alcoholic Fatty Liver Disease; Overweight; Resveratrol | 2022 |
Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults - A pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Overweight; Pilot Projects; Resveratrol; Risk Factors; Vascular Cell Adhesion Molecule-1 | 2020 |
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.
Topics: Adult; Aged; Body Composition; Dietary Supplements; Energy Metabolism; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Overweight; Physical Functional Performance; Quality of Life; Resveratrol | 2020 |
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women.
Topics: Absorptiometry, Photon; Adult; Bacteroidetes; Catechin; Double-Blind Method; Energy Metabolism; Faecalibacterium prausnitzii; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Muscle, Skeletal; Overweight; Polyphenols; Resveratrol; Stilbenes; Treatment Outcome | 2017 |
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Antioxidants; Dietary Supplements; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Intra-Abdominal Fat; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Overweight; Proton Magnetic Resonance Spectroscopy; Resveratrol | 2018 |
Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Cognition; Female; Humans; Male; Overweight; Pilot Projects; Psychomotor Performance; Resveratrol; Stilbenes | 2018 |
The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans.
Topics: Adipose Tissue; Adult; Catechin; Dietary Supplements; Double-Blind Method; Female; Gene Expression; Humans; Male; Obesity; Overweight; Polyphenols; Resveratrol | 2018 |
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Brachial Artery; Carotid Arteries; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Obesity; Overweight; Postmenopause; Resveratrol; Stilbenes; Stroop Test; Surveys and Questionnaires; Vasodilation | 2013 |
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
Topics: Adult; Analysis of Variance; Apolipoprotein B-100; Apolipoprotein B-48; Biomarkers; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Intestinal Mucosa; Intestines; Lipoproteins; Liver; Male; Middle Aged; Obesity; Ontario; Overweight; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects.
Topics: Adult; Antioxidants; Body Mass Index; Catechin; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Female; Humans; Lipid Metabolism; Male; Middle Aged; Overweight; Oxidation-Reduction; Polyphenols; Postprandial Period; Resveratrol; Stilbenes; Treatment Outcome | 2014 |
Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study.
Topics: Aged; Anthropometry; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Blood Pressure; Dietary Supplements; Female; Humans; Male; Overweight; Pilot Projects; Resveratrol; Stilbenes; Waist Circumference | 2014 |
Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
Topics: Aged; Apolipoprotein A-I; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Female; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Resveratrol; Stilbenes | 2015 |
Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
Topics: Administration, Oral; Adolescent; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Overweight; Pediatric Obesity; Resveratrol; Stilbenes | 2015 |
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult | 2016 |
Serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: A randomized trial.
Topics: Biomarkers; Caloric Restriction; Female; Gene Expression Regulation; Humans; Lipids; Male; Middle Aged; Overweight; Prospective Studies; Resveratrol; Sirtuin 1; Stilbenes | 2017 |
Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Overweight; Placebos; Resveratrol; Risk Factors; Stilbenes; Vasodilation | 2011 |
6 other study(ies) available for resveratrol and Overweight
Article | Year |
---|---|
Effects of a combination of resveratrol and alpha-lipoic acid on body weight and adipose composition in women with PCOS: a preliminary pilot study.
Topics: Female; Folic Acid; Humans; Overweight; Pilot Projects; Polycystic Ovary Syndrome; Quality of Life; Resveratrol; Thioctic Acid; Vitamin D | 2022 |
Dodging physical activity and healthy diet: can resveratrol take the edge off the consequences of your lifestyle?
Topics: Adult; Diet, Healthy; Dietary Supplements; Exercise; Humans; Insulin Resistance; Life Style; Overweight; Resveratrol | 2020 |
The effect of obesity and repeated exposure on pharmacokinetic response to grape polyphenols in humans.
Topics: Aged; Anti-Obesity Agents; Area Under Curve; Body Mass Index; Dietary Supplements; Female; Fruit; Fruit and Vegetable Juices; Humans; Kinetics; Male; Middle Aged; Obesity; Overweight; Pilot Projects; Plant Extracts; Polyphenols; Resveratrol; Seeds; Stilbenes; Vitis | 2017 |
Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length.
Topics: Dietary Supplements; Double-Blind Method; Humans; Insulin; Non-alcoholic Fatty Liver Disease; Overweight; Resveratrol | 2018 |
Protective effect of resveratrol on spermatozoa function in male infertility induced by excess weight and obesity.
Topics: Acrosin; Adult; Cell Survival; Cytoplasm; Gonadal Steroid Hormones; Humans; Infertility, Male; Male; Obesity; Overweight; Protective Agents; Resveratrol; Semen Analysis; Spermatozoa; Stilbenes; Zinc | 2016 |
Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.
Topics: Adipocytes; Adult; Antioxidants; Benzylamines; Biological Transport; Female; Glucose; Glycerol; Humans; Insulin; Isoproterenol; Lipogenesis; Lipolysis; Overweight; Primary Cell Culture; Resveratrol; Stilbenes; Subcutaneous Fat | 2013 |